Lb Pharmaceuticals Inc · NASDAQ:LBRX
Caligan Partners LP reported a 5.00% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Caligan Partners LP reported a 5.00% stake in Lb Pharmaceuticals Inc, 1,438,070 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 1,438,070
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 5.00% | 1,438,070 |
| JOHNSON DAVID EDWARD | 5.00% | 1,438,070 |
Source
Related
- Lb Pharmaceuticals Inc
- Caligan Partners LP
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026